KEAP1 and acute lymphoblastic leukemia: Since NRF2/KEAP1 axis is a redox regulator and a target of brusatol, we first evaluated the expression levels of NFE2L2 in ALL cell lines, which encodes for the NRF2 protein and KEAP1, the natural inhibitor of NRF2 (Figure 2).